Status:
COMPLETED
Effect of IATP on Cognitive Functioning in Anxious Older Adults.
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Anxiety Symptoms
Eligibility:
All Genders
60-90 years
Phase:
NA
Brief Summary
Older adults with anxiety symptoms was found to be associated with greater risk of dementia. Interventions targeting signs as early as in the pre-symptomatic phase could be most effective in early pre...
Detailed Description
Older adults with anxiety disorders or symptoms are not in the consideration of management for dementia prevention. However, the condition is found to be associated with profound negative subsequent d...
Eligibility Criteria
Inclusion
- Older adults aged 60 - 90 years; and
- Presence of subjective memory complaints as measured by memory inventory for the Chinese; and
- Anxiety symptoms as measured by Hamilton Anxiety Scale (HAM-A) with a score of 18 or above (indicated as mild anxiety symptoms).
Exclusion
- DSM-5 diagnosis of either Major Neurocognitive Disorder due to AD, or Major Vascular Neurocognitive Disorder with small vessel disease. This would include satisfying criteria for significant cognitive decline in at least one of six areas of cognition (memory, perceptual-motor, complex attention, language, executive function and social cognition), and with clinical or neuroimaging features indicative of either AD or small vessel disease; or;
- Clinical dementia rating larger than or equal to 0.5; or
- Clinically depressed as assessed by Hamilton Depression Rating Scale with a score of 20 or higher; or
- Past history of major depressive episode, bipolar affective disorders or psychosis; or
- Physical frailty that may affect attendance to training sessions; or
- Currently on psychotropic or other medications know to affect cognition (e.g., benzodiazepines, anti-dementia medication, etc.); or
- Participants in other cognitive training or intervention for brain health during the study period; or
- Presence of major neurological deficit including history of stroke, transient ischemic attack or traumatic brain injury; or
- Significant communicative impairment.
Key Trial Info
Start Date :
August 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 7 2019
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04413513
Start Date
August 13 2018
End Date
January 7 2019
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic University
Hong Kong, Hong Kong